Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.34) per share. This is unchanged from the same period last year.

EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol Use Disorder

By Vandana Singh

June 5, 8:00 AM

Adial Pharmaceuticals starts dosing in pharmacokinetics study of AD04 for Alcohol Use Disorder in heavy drinking patients. Topline results in early Q4 2024.

ADIL

Earnings

Preview: FTAI Infrastructure’s Earnings

By Benzinga Insights

July 24, 4:01 PM

FTAI Infrastructure (NASDAQ:FIP) is set to give its latest quarterly earnings report on Tuesday, 2023-07-25. Here’s what investors…

FIP

Top 5 Tech And Telecom Stocks That May Explode In Q4

By Lisa Levin

November 10, 9:51 AM

The most oversold stocks in the communication services sector presents an opportunity to buy into undervalued companies.

CDLX

Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday

By Lisa Levin

February 27, 11:21 AM

U.S. stocks traded higher, with the Dow Jones gaining more than 300 points on Monday. Here are some big stocks recording gains in today’s session.

AAMC

Milestone Pharmaceuticals Q3 EPS $(0.34), Same YoY

Related Posts

EXCLUSIVE: Adial Pharmaceuticals Starts Patient Dosing In Pharmacokinetics Study Of AD04 For Alcohol Use Disorder

Preview: FTAI Infrastructure’s Earnings

Top 5 Tech And Telecom Stocks That May Explode In Q4

Union Pacific, Kosmos Energy, Fisker And Other Big Stocks Moving Higher On Monday